# Treatment of Post-Chemo Cognitive Impairment w/Transcranial Magnetic Stimulation (Chemobrain TMS)

> **NCT04295720** · NA · TERMINATED · sponsor: **University of Arizona** · enrollment: 1 (actual)

## Conditions studied

- Chemo-brain

## Interventions

- **DEVICE:** Transcranial magnetic stimulation (TMS)

## Key facts

- **NCT ID:** NCT04295720
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-05
- **Primary completion:** 2022-01-03
- **Final completion:** 2022-03-30
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Stopped due to the risk of COVID-19 variants to our subject base of cancer patients
- **Last updated:** 2023-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04295720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04295720, "Treatment of Post-Chemo Cognitive Impairment w/Transcranial Magnetic Stimulation (Chemobrain TMS)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04295720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*